308 related articles for article (PubMed ID: 26675062)
1. Lung Size and the Risk of Radiation Pneumonitis.
Briere TM; Krafft S; Liao Z; Martel MK
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):377-84. PubMed ID: 26675062
[TBL] [Abstract][Full Text] [Related]
2. A little to a lot or a lot to a little? An analysis of pneumonitis risk from dose-volume histogram parameters of the lung in patients with lung cancer treated with 3-D conformal radiotherapy.
Willner J; Jost A; Baier K; Flentje M
Strahlenther Onkol; 2003 Aug; 179(8):548-56. PubMed ID: 14509954
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the relationship between gross tumor volume location and pneumonitis rates using a large clinical database of non-small-cell lung cancer patients.
Vinogradskiy Y; Tucker SL; Liao Z; Martel MK
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1650-8. PubMed ID: 21497454
[TBL] [Abstract][Full Text] [Related]
4. Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability.
Seppenwoolde Y; Lebesque JV; de Jaeger K; Belderbos JS; Boersma LJ; Schilstra C; Henning GT; Hayman JA; Martel MK; Ten Haken RK
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):724-35. PubMed ID: 12573760
[TBL] [Abstract][Full Text] [Related]
5. Predicting pneumonitis risk: a dosimetric alternative to mean lung dose.
Tucker SL; Mohan R; Liengsawangwong R; Martel MK; Liao Z
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):522-7. PubMed ID: 22580121
[TBL] [Abstract][Full Text] [Related]
6. Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
Piotrowski T; Matecka-Nowak M; Milecki P
Neoplasma; 2005; 52(1):56-62. PubMed ID: 15739028
[TBL] [Abstract][Full Text] [Related]
7. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
[TBL] [Abstract][Full Text] [Related]
8. Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy.
Ramella S; Trodella L; Mineo TC; Pompeo E; Stimato G; Gaudino D; Valentini V; Cellini F; Ciresa M; Fiore M; Piermattei A; Russo P; Cesario A; D'Angelillo RM
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):110-5. PubMed ID: 19619955
[TBL] [Abstract][Full Text] [Related]
9. [Non-small cell lung cancer: risk factors of radiation pneumonitis].
Giroux Leprieur E; Fernandez D; Chatellier G; Klotz S; Giraud P; Durdux C
Cancer Radiother; 2012; 16(4):257-62. PubMed ID: 22748977
[TBL] [Abstract][Full Text] [Related]
10. Decreased risk of radiation pneumonitis with incidental concurrent use of angiotensin-converting enzyme inhibitors and thoracic radiation therapy.
Kharofa J; Cohen EP; Tomic R; Xiang Q; Gore E
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):238-43. PubMed ID: 22300564
[TBL] [Abstract][Full Text] [Related]
11. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis.
Claude L; Pérol D; Ginestet C; Falchero L; Arpin D; Vincent M; Martel I; Hominal S; Cordier JF; Carrie C
Radiother Oncol; 2004 May; 71(2):175-81. PubMed ID: 15110451
[TBL] [Abstract][Full Text] [Related]
12. Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study.
Yorke ED; Jackson A; Rosenzweig KE; Braban L; Leibel SA; Ling CC
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):672-82. PubMed ID: 15939548
[TBL] [Abstract][Full Text] [Related]
13. Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy.
Yorke ED; Jackson A; Rosenzweig KE; Merrick SA; Gabrys D; Venkatraman ES; Burman CM; Leibel SA; Ling CC
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):329-39. PubMed ID: 12243805
[TBL] [Abstract][Full Text] [Related]
14. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
Murshed H; Liu HH; Liao Z; Barker JL; Wang X; Tucker SL; Chandra A; Guerrero T; Stevens C; Chang JY; Jeter M; Cox JD; Komaki R; Mohan R
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1258-67. PubMed ID: 15001271
[TBL] [Abstract][Full Text] [Related]
15. NTCP modelling and pulmonary function tests evaluation for the prediction of radiation induced pneumonitis in non-small-cell lung cancer radiotherapy.
Tsougos I; Nilsson P; Theodorou K; Kjellén E; Ewers SB; Jarlman O; Lind BK; Kappas C; Mavroidis P
Phys Med Biol; 2007 Feb; 52(4):1055-73. PubMed ID: 17264370
[TBL] [Abstract][Full Text] [Related]
16. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis.
Kong FM; Hayman JA; Griffith KA; Kalemkerian GP; Arenberg D; Lyons S; Turrisi A; Lichter A; Fraass B; Eisbruch A; Lawrence TS; Ten Haken RK
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(4):1075-86. PubMed ID: 16647222
[TBL] [Abstract][Full Text] [Related]
17. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
Yom SS; Liao Z; Liu HH; Tucker SL; Hu CS; Wei X; Wang X; Wang S; Mohan R; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):94-102. PubMed ID: 17321067
[TBL] [Abstract][Full Text] [Related]
18. Validation of Effective Dose as a Better Predictor of Radiation Pneumonitis Risk Than Mean Lung Dose: Secondary Analysis of a Randomized Trial.
Tucker SL; Xu T; Paganetti H; Deist T; Verma V; Choi N; Mohan R; Liao Z
Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):403-410. PubMed ID: 30291994
[TBL] [Abstract][Full Text] [Related]
19. Incorporating single-nucleotide polymorphisms into the Lyman model to improve prediction of radiation pneumonitis.
Tucker SL; Li M; Xu T; Gomez D; Yuan X; Yu J; Liu Z; Yin M; Guan X; Wang LE; Wei Q; Mohan R; Vinogradskiy Y; Martel M; Liao Z
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):251-7. PubMed ID: 22541966
[TBL] [Abstract][Full Text] [Related]
20. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC).
Graham MV; Purdy JA; Emami B; Harms W; Bosch W; Lockett MA; Perez CA
Int J Radiat Oncol Biol Phys; 1999 Sep; 45(2):323-9. PubMed ID: 10487552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
